Verrica Pharmaceuticals Inc (VRCA)
7.06
+0.07
(+1.00%)
USD |
NASDAQ |
Apr 17, 16:00
7.07
+0.01
(+0.14%)
After-Hours: 20:00
Verrica Pharmaceuticals Market Cap: 299.90M for April 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 16, 2024 | 296.51M |
| April 15, 2024 | 293.54M |
| April 12, 2024 | 291.42M |
| April 11, 2024 | 299.90M |
| April 10, 2024 | 304.99M |
| April 09, 2024 | 299.05M |
| April 08, 2024 | 296.93M |
| April 05, 2024 | 285.48M |
| April 04, 2024 | 272.33M |
| April 03, 2024 | 261.30M |
| April 02, 2024 | 249.85M |
| April 01, 2024 | 251.12M |
| March 28, 2024 | 251.12M |
| March 27, 2024 | 239.67M |
| March 26, 2024 | 225.67M |
| March 25, 2024 | 214.64M |
| March 22, 2024 | 212.52M |
| March 21, 2024 | 214.21M |
| March 20, 2024 | 210.40M |
| March 19, 2024 | 201.06M |
| March 18, 2024 | 201.49M |
| March 15, 2024 | 203.61M |
| March 14, 2024 | 207.85M |
| March 13, 2024 | 218.88M |
| March 12, 2024 | 220.58M |
| Date | Value |
|---|---|
| March 11, 2024 | 221.00M |
| March 08, 2024 | 212.52M |
| March 07, 2024 | 206.15M |
| March 06, 2024 | 210.82M |
| March 05, 2024 | 218.03M |
| March 04, 2024 | 235.42M |
| March 01, 2024 | 235.42M |
| February 29, 2024 | 223.55M |
| February 28, 2024 | 242.63M |
| February 27, 2024 | 240.51M |
| February 26, 2024 | 229.06M |
| February 23, 2024 | 219.73M |
| February 22, 2024 | 216.73M |
| February 21, 2024 | 211.64M |
| February 20, 2024 | 220.13M |
| February 16, 2024 | 230.94M |
| February 15, 2024 | 235.82M |
| February 14, 2024 | 223.94M |
| February 13, 2024 | 219.28M |
| February 12, 2024 | 243.88M |
| February 09, 2024 | 233.70M |
| February 08, 2024 | 222.25M |
| February 07, 2024 | 219.28M |
| February 06, 2024 | 227.34M |
| February 05, 2024 | 222.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
49.81M
Minimum
Jun 01 2022
449.26M
Maximum
Nov 26 2019
252.29M
Average
251.25M
Median
Dec 21 2021
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.471M |
| Palatin Technologies Inc | 30.50M |
| iBio Inc | 6.568M |
| Theriva Biologics Inc | 7.209M |
| Ampio Pharmaceuticals Inc | 0.2838M |
Market Cap Related Metrics
| PS Ratio | 62.55 |
| PEG Ratio | -0.0603 |
| Price to Book Value | 15.17 |
| Price | 7.06 |
| Earnings Yield | -20.79% |
| PEGY Ratio | -0.0603 |